Literature DB >> 3497685

Injection sclerotherapy in adult patients with extrahepatic portal venous obstruction.

D Kahn, J Terblanche, S Kitano, P Bornman.   

Abstract

Thirty-nine adult and teenage patients with extrahepatic portal venous obstruction (EHPVO) were treated with injection sclerotherapy. There were 22 males and 17 females with a mean age of 27 years (range 12-69). Oesophageal varices were eradicated in 33 patients after seven injections (range 1-17) over a mean of 14.5 months (range 1-48). Fewer injections were needed to eradicate varices in older patients. Variceal bleeding occurred on 13 occasions in 9 patients before eradication of varices and on 4 occasions in 4 of the 33 patients in whom varices had been eradicated, with a mean follow-up of 44 months (range 3-105). There were no deaths during the study period. Complications, mostly of a minor nature, occurred in 25 patients and included injection site leak in 5, stenosis in 7 and mucosal ulceration in 23. We conclude that injection sclerotherapy is the treatment of choice in patients with EHPVO.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497685     DOI: 10.1002/bjs.1800740720

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Esophageal transection may well be the approach of choice for patient with portal venous obstruction and esophageal varices.

Authors:  S Kitano; Y Iso; T Iwanaga; N Koyanagi; K Sugimachi
Journal:  Jpn J Surg       Date:  1989-07

Review 2.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

3.  Extrahepatic portal hypertension: long-term results of surgical treatment.

Authors:  A B Szczepanik; W J Rudowski
Journal:  Ann R Coll Surg Engl       Date:  1989-07       Impact factor: 1.891

4.  Sclerotherapy in extrahepatic portal venous obstruction.

Authors:  Y K Chawla; J B Dilawari; G N Ramesh; U Kaur; S K Mitra; B N Walia
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

5.  A 15-year experience of injection sclerotherapy in adult patients with extrahepatic portal venous obstruction.

Authors:  D Kahn; J E Krige; J Terblanche; P C Bornman; S C Robson
Journal:  Ann Surg       Date:  1994-01       Impact factor: 12.969

6.  Long-term injection sclerotherapy treatment for esophageal varices. A 10-year prospective evaluation.

Authors:  J Terblanche; D Kahn; P C Bornman
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

7.  Sclerotherapy in noncirrhotic portal fibrosis.

Authors:  Y K Chawla; J B Dilawari; R K Dhiman; M K Goenka; D K Bhasin; R Kochhar; K Singh; U Kaur
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

8.  Esophageal strictures following endoscopic variceal sclerotherapy. Antecedents, clinical profile, and management.

Authors:  R Kochhar; M K Goenka; S K Mehta
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

Review 9.  The surgeon's role in the management of portal hypertension.

Authors:  J Terblanche
Journal:  Ann Surg       Date:  1989-04       Impact factor: 12.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.